WIRE — A Consultant Nephrologist and Professor of Medicine, Professor Samuel Ajayi, has said the discovery of APOL1 kidney-risk gene variants is transforming the understanding, diagnosis and treatment of chronic kidney disease among people of African ancestry, offering new hope for millions of patients across the continent. Ajayi disclosed this while delivering a virtual lecture titled "APOL1 The post Gene discovery changing kidney disease treatment among Africans —Ajayi appeared first on Tribune Online.
"We aggregate wires to encourage regional discovery, sending readers directly back to the original source to explore full coverage."
This is a normalized overview of the breaking feed event. The complete, official release detailing all points, background context, and statements remains hosted by the original publisher.